Combined Treatment with Hyaluronic Acid and Mesalamine Protects Rats from Inflammatory Bowel Disease Induced by Intracolonic Administration of Trinitrobenzenesulfonic Acid

Drugs such as mesalamine (5-ASA) are currently recommended for the treatment of inflammatory bowel disease (IBD). To reduce the frequency of their administration and improve their therapeutic effect, this study investigated the adhesion efficacy, wound healing promotion, and decrease in inflammation...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Chih-Tung, Kuo, Sheng-Nan, Hung, Shao-Wen, Yang, Cheng-Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152619/
https://www.ncbi.nlm.nih.gov/pubmed/28556814
http://dx.doi.org/10.3390/molecules22060904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152619/
https://www.ncbi.nlm.nih.gov/pubmed/28556814
http://dx.doi.org/10.3390/molecules22060904

Ejemplares similares